Bioscience Valuation BSV GmbH
BioScience Valuation (BSV) is a consulting company working at the intersection of life sciences and finance. BSV is a trusted partner for Pharma and Biotech companies and their investors, with a 500+ mandates track record of private and public clients in Europe, the US, and worldwide.
Since 2000, the company has been at the forefront of translating scientific innovation into financial value. Our services cover the entire spectrum of commercial, R&D and financial analyses and deliver unparalleled evidence-based assessments. Based on our profound subject expertise and comprehensive database coverage, our appraisals demonstrate the route to value creation from seed stage to IPO and beyond.
Our strategic alliances enable us to reach out into the US and other markets and to communicate client equity stories within the international investor community.
BSV at a glance:
| Products/Services |
BSV provides a broad range of services tailored to the specific needs of each client:
Pharmaceutical companies Biotech/Medtech companies Investors Strategic alliances |
| Date of Incorporation | 2000 |
Contact:
Co-Founder
Managing Director,
Co-Founder
| Address | Am Zigeunerbergl 3 82491 Grainau |
| Telephone/Telefax | +49 8821 966 979-10 /-29 |
| contact@bioscience-valuation.com | |
| Web Address | www.bioscience-valuation.com |
| Social Media |
- Can biopharma’s drug-focused R&D strategy remain profitable?
- Strategic collaboration between NLC Health Ventures and BioScience Valuation (BSV)
- The advantage of early-stage biotech investing
- Im Auge des Sturms herrscht gelassene Ruhe
- „Wir setzen unsere Bewertungsmethoden dynamisch ein“
- Exploiting market inefficiencies in early-stage biotech investing
- Das Netzwerktreffen der Plattform Life Sciences 2022